Trials / Completed
CompletedNCT04584788
Validation of the O3 Regional Somatic Tissue Oxygenation Monitor
A Single-Center, Prospective Study in Healthy Volunteers for Validation of the O3 Regional Somatic Tissue Oxygenation Monitor
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Testing the absolute accuracy of the Masimo O3 regional oximeter in reading somatic tissue oxygenation in healthy volunteers under controlled hypoxia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Masimo O3 Regional Oximeter | Study sensors will be placed on somatic tissues. Readings will be taken from the tissues underneath the O3 sensors. |
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2021-06-02
- Completion
- 2021-06-02
- First posted
- 2020-10-14
- Last updated
- 2022-06-27
- Results posted
- 2022-06-27
Locations
1 site across 1 country: Netherlands
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04584788. Inclusion in this directory is not an endorsement.